SOD2 and hepatocellular carcinoma: These results highlight the notion that modulating elevated MnSOD that upregulates FoxM1 through an increased binding of E2F1 and Sp1 onto FoxM1 promoter is a novel way for suppressing carcinogenicity and stemness in HCSLCs to treat human hepatic carcinoma.